Rob Mettelman
banner
rmettelman.bsky.social
Rob Mettelman
@rmettelman.bsky.social
SJCRH Postdoc | Thomas Lab | T cell Immunity | Influenza | Virus Enthusiast | Incoming Asst Prof, Pitt CVR | New Dad
Reposted by Rob Mettelman
Overjoyed to share our new work exploring the antigen specificity of CSF-expanded CD8+ T cells in #multiplesclerosis #EBV in @natimmunol.nature.com #immunology 🧪🧵1/

www.nature.com/articles/s41...
Antigen specificity of clonally enriched CD8+ T cells in multiple sclerosis - Nature Immunology
Sabatino and colleagues examine expanded CD8+ T cell clonotypes from a small cohort of multiple sclerosis patients. They identified several cognate peptide epitopes that derive from Epstein–Barr virus...
www.nature.com
February 5, 2026 at 10:20 AM
Reposted by Rob Mettelman
Congratulations to now graduated PhD student Stephen Winston for leading this study on rAAV contaminants.

This study shows that a mere 2 nucleotide modification to the (Rep78/68 driving) p5 promoter results in rAAV with equivalent titers but ~50-fold lower p5-derived contaminants. #genetherapy #AAV
Rational engineering of the P5 TRS-mimic site and REP78/68 start codon yields promoter variants that improve rAAV vector purity while maintaining high titers.
During recombinant adeno-associated virus (rAAV) production, certain components of the manufacturing system can be encapsidated as unwanted nucleic acid contaminants. Prior work has established that t...
www.cell.com
January 31, 2026 at 2:07 AM
Reposted by Rob Mettelman
@CellPressNews For the #love of #TCRs -#Read this >#Scalable #TCR synthesis and screening enable antigen reactivity mapping... www.sciencedirect.com/science/arti...
Scalable TCR synthesis and screening enable antigen reactivity mapping in vitiligo
T cells initiate targeted immune responses using T cell receptors (TCRs) to recognize specific antigens. Mapping TCRs to antigens at scale remains a m…
www.sciencedirect.com
January 28, 2026 at 5:08 PM
Reposted by Rob Mettelman
Excited to see our paper out, it was a great team effort! Immune history confers antibody- and T cell-dependent cross-protection against highly pathogenic avian influenza H5N1 viruses | Journal of Virology journals.asm.org/doi/10.1128/...
Immune history confers antibody- and T cell-dependent cross-protection against highly pathogenic avian influenza H5N1 viruses | Journal of Virology
The rapid spread of highly pathogenic avian H5 influenza (HPAI) clade 2.3.4.4b in U.S. cattle represents an urgent and evolving public health threat. Our findings reveal that pre-existing immunity, whether from seasonal H1N1 infection or live-attenuated vaccination, can confer substantial protection against lethal bovine- and feline-derived HPAI H5N1 viruses, even in the absence of strong cross-neutralizing antibody titers. By integrating T cell epitope mapping with mechanistic depletion studies, we demonstrate that conserved CD4 and CD8 T cell epitopes across H1N1 and H5N1 strains underpin this cross-protection. Critically, loss of CD4 T cell help during primary H1N1 infection disrupts the development of cross-reactive antibody responses and markedly worsens outcomes after H5N1 challenge. These results identify memory T cell responses as important determinants of heterosubtypic immunity and highlight the need to incorporate T cell-focused metrics into risk assessment, vaccine evaluation, and preparedness strategies for emerging HPAI H5N1 viruses.
journals.asm.org
January 27, 2026 at 3:14 PM
Reposted by Rob Mettelman
Infectious diseases remain one of the greatest threats to children. As a WHO Collaborating Center for Influenza, St. Jude helps inform global flu vaccine decisions through year-round surveillance and data sharing.
January 26, 2026 at 5:45 PM
Reposted by Rob Mettelman
Ever wondered what happens if you remove Tfh cells from established germinal centres?
January 26, 2026 at 2:20 AM
Reposted by Rob Mettelman
Excited to announce the upcoming 2026 Microbial Toxins and Pathogenicity GRC and GRS meeting taking place July 12 - 17, 2026 at Waterville Valley in New Hampshire. This meeting will be chaired by yours truly and co-chaired by
@sunnyshinlab.bsky.social www.grc.org/microbial-to...
2026 Microbial Toxins and Pathogenicity Conference GRC
The 2026 Gordon Research Conference on Microbial Toxins and Pathogenicity will be held in Waterville Valley, New Hampshire. Apply today to reserve your spot.
www.grc.org
January 24, 2026 at 1:57 PM
Reposted by Rob Mettelman
Rhinoviruses cause common cold & asthma attacks but are also often benign. Using nasal organoids, we learned how the community of cells in the lining the nasal passages coordinates to respond to rhinovirus and which responses lead to excess mucus & inflammation. www.cell.com/cell-press-b...
Rhinovirus triggers distinct host responses through differential engagement of epithelial innate immune signaling
Rhinoviruses are the most frequent cause of common colds and also a major cause of respiratory distress in high-risk groups. Using single-cell sequencing of rhinovirus-infected nasal epithelial organo...
www.cell.com
January 20, 2026 at 9:23 PM
Reposted by Rob Mettelman
Six leading medical organizations plan to ask the courts to throw out revisions to the childhood vaccination schedule announced last week by Health Secretary Robert F. Kennedy Jr. and other federal officials.

(Gift link)
www.nytimes.com/2026/01/13/h...
Medical Groups Will Try to Block Childhood Vaccine Recommendations
www.nytimes.com
January 13, 2026 at 4:16 PM
Reposted by Rob Mettelman
Delighted that our latest paper is out at @mucosalimmunol.bsky.social. Here, using bronchoscopies and scRNA- and TCR-seq, we found that T cells isolated from bronchoalveolar lavage versus the airway mucosal are surprisingly distinct. Summary of the original preprint below. #Immunology #PCCM
January 9, 2026 at 2:14 PM
Reposted by Rob Mettelman
Reposted by Rob Mettelman
Virus-specific CD8+ tissue-resident memory T cells trigger epithelial antiviral defenses via IFNγ @cp-immunity.bsky.social @emoryuniversity.bsky.social
www.cell.com/immunity/ful...
November 26, 2025 at 8:35 PM
Reposted by Rob Mettelman
Excited to see our TIRTL-seq method published in Nature Methods www.nature.com/articles/s41...! Some updates after the revision: (1/4)
TIRTL-seq: deep, quantitative and affordable paired TCR repertoire sequencing - Nature Methods
TIRTL-seq is a high-throughput method for paired T cell receptor sequencing at the cohort scale.
www.nature.com
November 25, 2025 at 10:38 PM
Reposted by Rob Mettelman
We are #absolutely #thrilled to #present @cp-immunity.bsky.social - Deep profiling of human T cells defines compartmentalized clones and phenotypic trajectories across blood and tonsils: Immunity www.cell.com/immunity/ful...
Deep profiling of human T cells defines compartmentalized clones and phenotypic trajectories across blood and tonsils
Human T cell responses are often studied using blood, yet most T cells reside in tissues. By comparing T cell receptor repertoires from millions of T cells from autologous tonsils and blood, Sureshcha...
www.cell.com
November 26, 2025 at 3:47 PM
Reposted by Rob Mettelman
November 25, 2025 at 7:18 PM
Reposted by Rob Mettelman
High expression of IL-18 receptor alpha correlates with severe respiratory viral disease and defines T cells with reduced cytotoxic signatures
www.nature.com/articles/s41... @natcomms.nature.com @katherinekedz.bsky.social
@thedohertyinst.bsky.social @unimelb.bsky.social
November 25, 2025 at 7:26 PM
Reposted by Rob Mettelman
FLC is a rare, aggressive liver cancer lacking effective systemic therapies. Our vaccine targets the recurrent DNAJB1::PRKACA fusion, offering a universal neoantigen to drive anti-tumor immunity. www.nature.com/articles/s41...
A therapeutic peptide vaccine for fibrolamellar hepatocellular carcinoma: a phase 1 trial - Nature Medicine
In this phase 1 trial, treatment of patients with fibrolamellar hepatocellular carcinoma with a therapeutic peptide vaccine targeting the fusion kinase DNAJB1–PRKACA, which is the driver of the diseas...
www.nature.com
November 24, 2025 at 9:38 PM
Reposted by Rob Mettelman
Two complementary studies from our group out today: a therapeutic peptide vaccine trial for fibrolamellar carcinoma (FLC) & TIRTL-Seq, our robust method for deep quantitative paired TCR sequencing a🧵w/ @markyarchoan.bsky.social & @pogorely.bsky.social www.nature.com/articles/s41...
TIRTL-seq: deep, quantitative and affordable paired TCR repertoire sequencing - Nature Methods
TIRTL-seq is a high-throughput method for paired T cell receptor sequencing at the cohort scale.
www.nature.com
November 24, 2025 at 9:38 PM
Reposted by Rob Mettelman
After many rewarding years at @StJudeResearch surrounded by exceptional colleagues & groundbreaking science, I’m delighted to join @fredhutch to push boundaries in viral & cancer immunology. Grateful to St. Jude and looking forward to what’s next at FH! More here: www.fredhutch.org/en/news/cent...
Viral immunologist taps ‘incredible potential’ of immune system
New Fred Hutch Cancer Center viral immunologist Dr. Paul Thomas is working to turn the "incredible potential" of the immune system into real-life diagnostic and therapeutic applications. He studies ho...
www.fredhutch.org
November 7, 2025 at 9:12 PM
Reposted by Rob Mettelman
Multisystem inflammatory syndrome in children is a SARS-CoV-2 triggered Kawasaki disease

Like post acute infection syndrome, tihis is not new. But, we now have identified a trigger, and have more early event data.

www.nature.com/artic...
1/4
Multisystem inflammatory syndrome in children is a SARS-CoV-2 triggered Kawasaki disease
Pediatric Research - Multisystem inflammatory syndrome in children is a SARS-CoV-2 triggered Kawasaki disease
www.nature.com
October 28, 2025 at 4:23 PM
Reposted by Rob Mettelman
Antiviral MX1 transiently associates in the cytoplasm with neosynthesized viral ribonucleoproteins and, using dynein, reroutes them toward the microtubule organizing center where they remain sequestered
www.pnas.org/doi/10.1073/...
October 9, 2025 at 12:23 AM
Reposted by Rob Mettelman
New study reveals pasteurized milk containing H5N1 influenza viral components poses minimal health risks and doesn’t alter influenza immunity. Regularly drinking contaminated pasteurized milk doesn’t increase flu susceptibility in model systems. ow.ly/stPC50X32eB
September 26, 2025 at 6:05 PM
Reposted by Rob Mettelman
Very pleased to publish this new review with Farah Wahbeh on the role of #EBV in #Multiplesclerosis. I learned a lot writing this, I hope others find it useful too

www.neurology.org/doi/10.1212/...
Epstein-Barr Virus in Multiple Sclerosis | Neurology Neuroimmunology & Neuroinflammation
Epstein-Barr virus (EBV) is a very common herpesvirus that infects more than 90% of the general population. Epidemiologic data indicate that EBV is a requisite risk factor for the development of multi...
www.neurology.org
September 16, 2025 at 1:51 PM
Reposted by Rob Mettelman
We are hiring! The Dept of Microbiology and Molecular Genetics is looking for faculty at the Assistant or Associate professor level (tenure track). Please consider joining our vibrant microbiology and immunology community at the University of Pittsburgh School of medicine
August 20, 2025 at 7:41 PM
Reposted by Rob Mettelman
What's the difference between Trm and exhausted CD8 T cells? Simone Park's new work dissects this important question. These cell types are often confused, but are ontologically and mechanistically distinct with implications for immunotherapy responses. www.biorxiv.org/content/10.1...
Divergent ontogeny of Tissue Resident Memory and Tissue Resident Exhausted CD8+ T cells underlies distinct functional potential
Persistent antigen stimulation promotes differentiation of exhausted CD8+ T (TEX) cells. TEX cells are distinct from circulating memory T (TCIRCM) cells but share many features with tissue-resident me...
www.biorxiv.org
August 14, 2025 at 5:30 PM